The Rise of GLP-1 Receptor Agonists in Diabetes Management
Received Date: Sep 02, 2024 / Published Date: Sep 30, 2024
Abstract
The management of type 2 diabetes mellitus (T2DM) has evolved significantly in recent years, particularly with the introduction of glucagon-like peptide-1 (GLP-1) receptor agonists. These innovative medications offer not only effective glycemic control but also additional benefits such as weight loss and cardiovascular protection. This article reviews the mechanisms of action, clinical efficacy, recent developments, and future directions of GLP-1 receptor agonists in diabetes management, highlighting their role as a new standard of care.
Keywords: GLP-1 Receptor Agonists; Type 2 Diabetes; Glycemic Control; Weight Loss; Cardiovascular Benefits; Renal Protection; Dia- betes Management Guidelines; Patient Acceptance
Citation: Oliver J (2024) The Rise of GLP-1 Receptor Agonists in Diabetes Management. J Diabetes Clin Prac 7: 270 Doi: 10.4172/jdce.1000270
Copyright: © 2024 Oliver J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 87
- [From(publication date): 0-0 - Feb 22, 2025]
- Breakdown by view type
- HTML page views: 61
- PDF downloads: 26
